Aim Chronic obstructive pulmonary disease (COPD) patients vary widely in terms of the
prevalence of sarcopenia, which is partially attributed to differences in diagnostic criteria and …

Sarcopenia prevalence and its risk factors in chronic obstructive pulmonary disease (COPD)
vary partly due to definition criteria. This systematic review aimed to identify the prevalence …

Objective This study aims to assess the associations of complete blood cell count (CBC)-
derived inflammatory biomarkers with the prevalence of asthma and mortality. Methods Data …

Background Sarcopenia, common in the elderly, often linked to chronic diseases, correlates
with inflammation. The association between SII and mortality in sarcopenia patients is …

Background: Patients with chronic obstructive pulmonary disease (COPD) have alterations
in body composition, such as low cell integrity, body cell mass, and disturbances in water …

Background/Objective: Systemic inflammation is common in chronic obstructive pulmonary
disease (COPD), and evidence suggests that inflammatory biomarkers can predict acute …

Introduction This study explored the relationship between environmental polycyclic aromatic
hydrocarbons (PAHs) and Chronic obstructive pulmonary disease (COPD), and identified …

Background Asthma is associated with persistent airway inflammation, and numerous
studies have investigated inflammatory markers causing asthma. However, the systemic …

Background: Sarcopenia seems to be an emerging health issue worldwide, concerning the
progressive loss of skeletal muscle mass, accompanied by adverse outcomes. Asthma is a …

Background Sarcopenia, characterized by progressive muscle dysfunction, is a common
complication of chronic obstructive pulmonary disease (COPD). Our previous study revealed …